EUVIMEDOdkrijte EUVIMED
Open access

Benchmarking reverse docking through AlphaFold2 human proteome

Qing Luo, Sheng Wang, Hoi Yeung Li, Liangzhen Zheng, Yuguang Mu, Jingjing Guo iD

Protein Science · 2024

DOI: 10.1002/pro.5167 ↗

At a glance

Journal article in Protein Science, 2024. Written by Qing Luo and 5 co-authors. Institution: Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China. Major MEDLINE topics: Proteome, Molecular Docking Simulation. Cited 10 times so far (Crossref); 56 references. The full text is freely available in PubMed Central. Funded by: Macao Polytechnic University, Ministry of Education Singapore, National Key R&D Program of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Predicting the binding of ligands to the human proteome via reverse‐docking methods enables the understanding of ligand's interactions with potential protein targets in the human body, thereby facilitating drug repositioning and the evaluation of potential off‐target effects or toxic side effects of drugs. In this study, we constructed 11 reverse docking pipelines by integrating site prediction tools (PointSite and SiteMap), docking programs (Glide and AutoDock Vina), and scoring functions (Glide, Autodock Vina, RTMScore, DeepRMSD, and OnionNet‐SFCT), and then thoroughly benchmarked their predictive capabilities. The results show that the Glide_SFCT (PS) pipeline exhibited the best target prediction performance based on the atomic structure models in AlphaFold2 human proteome. It achieved a success rate of 27.8% when considering the top 100 ranked prediction. This pipeline effectively narrows the range of potential targets within the human proteome, laying a foundation for drug target prediction, off‐target assessment, and toxicity prediction, ultimately boosting drug development. By facilitating these critical aspects of drug discovery and development, our work has the potential to ultimately accelerate the identification of new therapeutic agents and improve drug safety.

Subjects

MeSH terms (MEDLINE)

ProteomeMolecular Docking SimulationHumansBenchmarkingSoftwareLigandsProtein BindingProtein Conformation

Author keywords

drug discoverydrug–target interactionhuman proteomereverse dockingtarget prediction

Substances

ProteomeLigands

Authors and institutions

  • Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
  • Shanghai Zelixir Biotech Company Ltd., China.
  • School of Biological Sciences, Nanyang Technological University, Singapore.
  • Shenzhen Zelixir Biotech Company Ltd., China.
  • Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

ORCID profiles: Jingjing Guo

Funding

  • Macao Polytechnic University
  • Ministry of Education Singapore
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Cite

APA

Luo, Q., Wang, S., Li, H. Y., Zheng, L., Mu, Y., & Guo, J. (2024). Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. https://doi.org/10.1002/pro.5167

Vancouver

Luo Q, Wang S, Li HY, Zheng L, Mu Y, Guo J. Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. 2024. doi:10.1002/pro.5167

BibTeX
@article{Luo2024,
  author = {Luo, Qing and Wang, Sheng and Li, Hoi Yeung and Zheng, Liangzhen and Mu, Yuguang and Guo, Jingjing},
  title = {Benchmarking reverse docking through AlphaFold2 human proteome},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5167}
}
Start for free →